Skip to content

MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner.

Daniel José Barbosa, Roman Serrat, Serena Mirra, Martí Quevedo, Elena Goméz De Barreda, Jesús Àvila, Eduarda Fernandes, Maria de Lourdes Bastos, João Paulo Capela, Félix Carvalho, Eduardo Soriano

Archives of Toxicology August 2014 DOI: 10.1007/s00204-014-1209-7 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Population Hippocampal neurons
Intervention MDMA
Topics MDMA
Key points MDMA markedly reduced mitochondrial trafficking in hippocampal neurons in a Tau-dependent manner, with glycogen synthase kinase 3β activity implicated. The trafficking abnormalities were rescued by over-expression of Mitofusin2 and dynamin-related protein 1, but not Miro1. The authors propose this as a novel mechanism that may contribute to how MDMA alters neuronal functioning.

Abstract

Identification of the mechanisms by which drugs of abuse cause neuronal dysfunction is essential for understanding the biological bases of their acute and long-lasting effects in the brain. Here, we performed real-time functional experiments of axonal transport of mitochondria to explore the role of in situ mitochondrial dysfunction in 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy")-related brain actions. We showed that MDMA dramatically reduced mitochondrial trafficking in hippocampal neurons in a Tau-dependent manner, in which glycogen synthase kinase 3β activity was implicated. Furthermore, we found that these trafficking abnormalities were rescued by over-expression of Mitofusin2 and dynamin-related protein 1, but not of Miro1. Given the relevance of mitochondrial targeting for neuronal function and neurotransmission, our data underscore a novel mechanism of action of MDMA that may contribute to our understanding of how this drug of abuse alters neuronal functioning.

Citations in the library

Cited by 6

and 1 more in the library

Cites 13

and 8 more in the library

Explore topics